MLchartDataset catalogue

SGN-35

Term · Oncology and biomedicine · MLC-T-ONC-007725

A drug used alone or with other drugs to treat adults with certain types of classic Hodgkin lymphoma, cutaneous or systemic anaplastic large cell lymphoma, large B-cell lymphoma, mycosis fungoides, or peripheral T-cell lymphoma, and with other drugs to treat children aged 2 years and older with certain types of classic Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. SGN-35 contains a monoclonal antibody that binds to a protein called CD30, which is found on some lymphoma cells. It also contains an anticancer drug, which may help kill cancer cells. SGN-35 is a type of antibody-drug conjugate. Also called Adcetris and brentuximab vedotin.

Table 1. Record
IdentifierMLC-T-ONC-007725
FieldOncology and biomedicine
ExpansionsAdcetris; brentuximab vedotin
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-007725",
  "term": "SGN-35",
  "field": "Oncology and biomedicine",
  "definition": "A drug used alone or with other drugs to treat adults with certain types of classic Hodgkin lymphoma, cutaneous or systemic anaplastic large cell lymphoma, large B-cell lymphoma, mycosis fungoides, or peripheral T-cell lymphoma, and with other drugs to treat children aged 2 years and older with certain types of classic Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. SGN-35 contains a monoclonal antibody that binds to a protein called CD30, which is found on some lymphoma cells. It also contains an anticancer drug, which may help kill cancer cells. SGN-35 is a type of antibody-drug conjugate. Also called Adcetris and brentuximab vedotin.",
  "expansions": [
    "Adcetris",
    "brentuximab vedotin"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/sgn-35/"
}

Record 14,917 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.